Department of Otolaryngology, Eye, Ear, Nose & Throat Hospital, Ear, Nose & Throat Institute, Fudan University, Shanghai, People's Republic of China; Clinical and Research Center for Olfactory Disorders, Eye, Ear, Nose & Throat Hospital, Fudan University, Shanghai, People's Republic of China.
School of Life Sciences, Shanghai University, Shanghai, People's Republic of China.
J Biol Chem. 2022 Sep;298(9):102331. doi: 10.1016/j.jbc.2022.102331. Epub 2022 Aug 1.
G protein-coupled olfactory receptors (ORs) enable us to detect innumerous odorants. They are also ectopically expressed in nonolfactory tissues and emerging as attractive drug targets. ORs can be promiscuous or highly specific, which is part of a larger mechanism for odor discrimination. Here, we demonstrate that the OR extracellular loop 2 (ECL2) plays critical roles in OR promiscuity and specificity. Using site-directed mutagenesis and molecular modeling, we constructed 3D OR models in which ECL2 forms a lid over the orthosteric pocket. We demonstrate using molecular dynamics simulations that ECL2 controls the shape and volume of the odorant-binding pocket, maintains the pocket hydrophobicity, and acts as a gatekeeper of odorant binding. Therefore, we propose the interplay between the specific orthosteric pocket and the variable, less specific ECL2 controls OR specificity and promiscuity. Furthermore, the 3D models created here enabled virtual screening of new OR agonists and antagonists, which exhibited a 70% hit rate in cell assays. Our approach can potentially be generalized to structure-based ligand screening for other G protein-coupled receptors that lack high-resolution 3D structures.
G 蛋白偶联嗅觉受体(ORs)使我们能够检测到无数的气味物质。它们也在非嗅觉组织中异位表达,并成为有吸引力的药物靶点。ORs 可以是混杂的或高度特异性的,这是气味辨别更大机制的一部分。在这里,我们证明 OR 的细胞外环 2(ECL2)在 OR 的混杂性和特异性中起着关键作用。通过定点突变和分子建模,我们构建了 3D OR 模型,其中 ECL2 在正位口袋上形成一个盖子。我们通过分子动力学模拟证明,ECL2 控制着气味结合口袋的形状和体积,保持口袋的疏水性,并作为气味结合的守门员。因此,我们提出特定的正位口袋和可变的、非特异性更强的 ECL2 之间的相互作用控制着 OR 的特异性和混杂性。此外,这里创建的 3D 模型能够对新的 OR 激动剂和拮抗剂进行虚拟筛选,在细胞测定中显示出 70%的命中率。我们的方法可以推广到缺乏高分辨率 3D 结构的其他 G 蛋白偶联受体的基于结构的配体筛选。